- Global Pharma News & Resources

Platelet Concentration Systems Market to Surpass US$ 1,110.4 Million by 2027, At a CAGR of 21.2% | Coherent Market Insights

SEATTLE, May 04, 2021, (PHARMIWEB) —

The global platelet concentration systems market is expected to see significant growth during the forecast period, due to the growing number of product approvals and presentation by major players. For instance, in 2018, Bellus Medical, a leader in medical aesthetics, introduced a progen PRP program used for orthopedics, wound care, aesthetics, heart, and nerve pain, accelerating muscle integration and providing a faster and more effective healing process.

Moreover, in August 2019, Healeon Medical, Inc., a wholly owned subsidiary of Bimini Health Tech, received US FDA 510 (K) approval for its Healeon Duet (BK200449), a plasma-rich plasma (PRP) preparation program.

Request a sample copy of this report@

Impact of Coronavirus (Covid-19) Pandemic

Platelet concentration systems are designed to protect plasma richly safely and quickly in a care setting from a small sample of a patient’s blood sample.

Since the outbreak of the COVID-19 virus in December 2019, the disease has spread to more than 100 countries around the world where the World Health Organization has declared it a public health emergency. According to a World Health Organization report, an outbreak of coronavirus (COVID-19) has caused death of over 63.3 million people worldwide since 30 November 2020.

COVID-19 can affect the global economy in three main ways; by directly affecting production and demand, by creating consumer and market disruption, and by its financial impact on financial firms and markets. Due to the closure, many countries such as Italy, Spain, and the U.K., the U.S., Australia, India, and others are facing problems with the provision and demand of Platelet Concentration Systems

The global platelet concentration systems market is expected to exhibit a CAGR of 21.2% over the period (2020-2027), due to increased implementation and adoption of platelet aggregation systems

Among other technologies, part of the apheresis technology is expected to hold a larger budget by 2027. Apheresis is a medical procedure in which a patient or donor’s blood is drawn and divided into such components as red cells, white cells, plasma, and platelets.

Major players working in the global platelet concentration systems market include Anthrax Inc., Stryker Corporation, Johnson & Johnson’s, Zimmer Biomet Holdings Inc., Terumo Corporation, Arteriocyte Medical Systems, Inc., Exactech Inc., Harvest Technologies Corp, YiNuo Therapeutics, Inc.

Buy This Complete A Business Report:

Detailed Segmentation:

By Technology:

    • Apheresis Technology
    • Single Spin Technology
    • Double Spin Technology

By End User:

    • Hospital
    • Orthopedic Clinics
    • Sports Injury Centers
    • Ambulatory Surgical Centers

View Press Release For More Information @

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contacts US:

Mr. Shah
Coherent Market Insights,
1001 4th Ave,
#3200 Seattle, WA 98154, U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 24-Oct-2021